Position Summary

Responsible for leading a focused team advancing next-generation tumor-infiltrating lymphocyte (TIL) therapies. This role seeks to reprogram and optimize TILs through integrated media, pharmacologic, and gene engineering strategies to enhance potency, persistence, and clinical efficacy. This position sits at the interface of deep biological discovery and disciplined product development, translating mechanistic insights into scalable processes and IND-ready cell therapy candidates. The successful candidate will play a key role in disrupting current TIL paradigms and advancing transformative therapies from concept to early clinical development.

Job Responsibilities